|Minimum Order Quantity||1 Pack|
|Shelf life||More than 2 years|
Ledikast( Ledipasvir& Sofosbuvir Tablets)
The fixed-dose combination of ledipasvir-sofosbuvir provides an effective and well-tolerated one-pill once-a-day option for treatment of genotypes 1, 4, 5, and 6 chronic hepatitis C (HCV) infection. This direct-acting antiviral regimen was the first FDA-approved interferon- and ribavirin free regimen to treat hepatitis C.
- Production Capacity: 1000000
- Delivery Time: 5 to 6 working days
- Packaging Details: In one Bottle has 28 tablets